pre-feasibility report - environmentclearance.nic.in · pre-feasibility report highlighting the...

PRE-FEASIBILITY REPORT

(Proposed Project (EC Permitted) of Active Pharmaceuticals Ingredients (APIs) from API Intermediates

Manufacturing Unit)

Of

M/s. Tejashrri Intermediates Pvt Ltd Sy. No. 94,

Rahimkhanpet (V), Atmakur (M), Yadadri Bhuvanagri District, Telangana State

KKB Envirocare Consultants Private Limited Hyderabad

NABET/EIA/1619/RA 0035 valid upto 06-08-2019

October 2017

i

Contents

S. No. Description Page No.

1.0 Executive Summary 1

1.1 Salient Features of the Project 2

2.0 Project Highlights 3 2.1 Identification of the Project and project proponent 3 2.2 Brief description of Nature of the Project 4

2.3 Need for the Project and its importance to the country and or region

5

2.4 Demand and Supply Gap 5

2.5 Imports Vs. Indigenous production, Export Possibility, Domestic/Export Markets

6

2.6 Employment Generation due to the proposed expansion project 6

3.0 Project Description 6

3.1 Type of the project 6 3.2 Location 6 3.3 Alternate sites 7

3.4 Size or magnitude of operation 7

3.5 Project description with Process Details

8 3.6 Raw materials 8 3.7 Resources optimization / recycling and reuse 8 3.8 Availability of water and Energy 9

3.9 Quantity of Wastes Generation and their Management / Disposal

9

3.9.1 Water requirement and Wastewater generation and their Management / Disposal

9

3.9.2 Hazardous / Solid Waste Generation, Handling and their Disposal

11

3.10 Schematic flow sheet for EIA procedure 11

4.0 Site Analysis 11

4.1 Connectivity 11 4.2 Land Form, Land use and Land ownership 12 4.3 Topography 12 4.4 Existing Land use pattern 12 4.5 Existing Infrastructure 12 4.6 Soil Classification 12

ii

S. No. Description Page No.

4.7 Climate data from Secondary sources 12 4.8 Social Infrastructure 13

5.0 Planning 13 5.1 Planning Concept 13 5.2 Population Projection 13 5.3 Land use planning 13 5.4 Assessment of Infrastructure Demand 14 5.5 Amenities/Facilities 14

6.0 Proposed Infrastructure 14 6.1 Industrial Area 14 6.2 Residential Area 14 6.3 Green Belt 14 6.4 Social Infrastructure 14 6.5 Connectivity 14 6.6 Drinking Water management 14 6.7 Sewerage System 14 6.8 Industrial Waste Management 14 6.9 Hazardous/ Solid Waste Management 17 6.10 Power Requirement & Supply / Source 17

7.0 Rehabilitation and Resettlement (R&R) Plan 17 8.0 Project Schedule & Cost Estimates 18

8.1 Time Schedule for the project construction 18 8.2 Estimated project cost 18

9.0 Analysis of proposal (Final Recommendations) 18 9.1 Budgetary allocation for Pollution Control Measures 18

iii

List of Tables

Table Title Page No.

1 Permitted Products as per EC & CTE and their Capacities 7

2 Water Balance and segregation and Treatment 10

3 Effluent Treatment Flow for as per Segregation 10

4 Hazardous / Solid Waste Generation from the Proposed

Products 11

5 Environmental Components Shortest distance from Project

Periphery 12

6 Land Breakup details 14

7 Maximum Quantity of Process Emission for Proposed Products 15

8 Stack Emission Details 16

iv

LIST of Annexures

Annexure No.

Title Page No.

I ROC copy 19 II Environmental Clearance Vide F.No.J-11011/515/2007-IA II (I) dated 23-

10-2007 20-24

III PH Minutes 25-33

IV CTE issued by APPCB vide order No. 267/PCB/CFE/RO-NLG/HO/2011-

2269 dated 24-10-2011 34-41

V Application for EC Validity extension was submitted to MoEF vide letter

dated 11-06-2012 42

VI Minutes of 3rd Reconstituted EAC Meeting 43-44

VII Screenshot showing project file as delisted 45

VIII EC Validity Extension copy dated 15-2-2017 46-47

IX General Location Map 48

X Specific Location (Route Map) 49

XI Google Map with project site 50

XII Plant layout 51

XIII Project description & Flow Chart 52-69

XIV List of Raw materials 70-77

XV List of Hazardous chemicals 78

XVI ETP Flow Chart 79

XVII Schematic flow Sheet for EIA Procedure 80-81

XVIII Topomap of 10 km radius 82

M/s. Tejashrri Intermediates Pvt. Ltd. Pre-Feasibility Report

1

Pre-Feasibility Report for Active Pharmaceutical Ingredients (APIs) Manufacturing Unit

1.0 Executive Summary

M/s. Tejashrri Intermediates Pvt. Ltd., an Active Pharmaceutical Ingredient (APIs) &

Intermediates manufacturing unit is located at Sy. No. 94, Rahimkhanpet (V), Atmakur (M),

Yadadri Bhuvanagiri District (formerly Nalgonda District), Telangana State with total area of

5.9488 Ha. The industry had already obtained Environmental Clearance (EC) Vide F.No.J-

11011/515/2007-IA II (I) dated 23-10-2007 and Consent to Establishment from the then APPCB

(presently TSPCB) but however, could not complete the implementation of the EC owing to

various reasons.

Background of the Industry:

Tejashrri Drugs & Intermediates Pvt. Ltd. incorporated into Registrar of Companies on 06-01-2005

(ROC enclosed as Annexure-I). Industry had proposed to set up an APIs and intermediates

manufacturing unit in 2007 and obtained Environmental Clearance Vide F.No.J-11011/515/2007-

IA II (I) dated 23-10-2007 (Annexure-II). Public Hearing for the project was conducted by APPCB

on 30-04-2007 (PH Minutes are enclosed as Annexure-III).

Owing to moratorium imposed by the then APPCB, there was delay in issuing Consent to

Establishment (CTE). However CTE was later issued in 2011 by APPCB vide order No.

267/PCB/CFE/RO-NLG/HO/2011-2269 dated 24-10-2011 (Annexure-IV). By then EC validity was

about to get expired. Industry could not implement the activity due to various issues as per EC &

CTE.

Application for EC Validity extension was submitted to MoEF vide letter dated 11-06-2012

(Annexure-V). Proposal for EC validity extension was considered in 3rd Reconstituted EAC

meeting held during 3rd – 5th December, 2012. EAC recommended for EC validity extension for

another 5 years (Minutes of 3rd Reconstituted EAC Meeting is enclosed as Annexure-VI). However, signed EC extension validity was not received. Upon tracking in MoEF&CC website, we

were unable to trace the file (file No. J-11011/253/2012-IA.II (I)) and it was shown as delisted

(Screenshot is enclosed as Annexure-VII).

Resubmitted an application for EC validity extension on 01-12-2016 and validity of EC was

extended upto 22-10-2017 i.e. total 10 years vide letter No. J-11011/253/2012-IA-II (I) dated

15-02-2017 (Annexure-VIII).

Now the industry is on verge of completing the project which requires maximum 3 to 4 months. As

the validity of the EC is about get lapsed by 10 years, since there is no provision for temporary

extension and in order to complete the implementation as per the permitted EC, application in

online Form-1 duly filled in and PFR is being submitted for ToR & EC as per the permitted EC to


2

complete the implementation of the project with a request to exempt the industry from Public

Hearing..

The proposal is implementation of permitted project from the Ministry of Environment, Forests and

Climate Change (MoEF&CC) to complete the project of manufacturing earlier EC permitted 3

campaign products at a time out of 12 APIs with a production capacity of 384 TPA and its by-

products with a total investment of Rs. 4.85 Crores.

The proposed project falls under the Category ‘A’, project or activity 5(f) according to the

EIA Notification 2006.

1.1 Salient Features of the Project:

• Proposing EC permitted project in the existing area of 5.9488 Ha.

• The proposed project is to manufacture any 3 products out of total 12 products with a

production capacity of 384 TPA along with its by-products.

• Total Greenbelt area is 3 Ha (50.4%).

• Project site is located at an aerial distance of

• 0.25 km (N) to road connecting Mothkur and Rayagiri villages which further connects to

National Highway – 163 (previously NH-202)

• 1.8 km (NNW) to Rahimkhanpet village & 1.85 km (NE) to Kapraipalli village

• 7 km (W) to Atmakur village

• 56 km (W) to Hyderabad ORR

• 23 km (SW) to Valigonda Railway Station & 27 km (NW) to Wangapally Railway station.

• 82 km (SW) to Rajiv Gandhi International Airport, Hyderabad

• Total cost of the project is Rs. 4.85 Crores. Total capital cost allocated towards

environmental pollution control measures is Rs. 50 lakhs. Recurring cost will be about Rs. 10

lakhs per annum.

• Total water requirement will be about 62.12 KLD and treated water will be recycled water

from ETP. Fresh water will be met from Groundwater from existing Bore wells.

• The proposed power requirement (Connected Load) of the plant is 250 HP. Power will be

met from Telangana State Power Distribution Corporation.

• DG sets would be 2 x 125 KVA (EC & CTE permitted). DG sets are used as standby during

power failure. Diesel of about 69 lit/hr will be used in the 2 x 125 KVA and EC & CTE

permitted 2 lakh Kcal/hr diesel fired Thermic Fluid Heater.


3

• Total 97 employees will be benefitted due to the proposed project. Out of which 62 will be

direct and 35 employees will be indirect.

• Coal of about 8 TPD will be used in the EC & CTE permitted 2 TPH coal fired boiler.

• Industry will provide dual scrubbers based on the characteristics of process emissions.

Boilers will be provided with multi-cyclone separator & bag filter to reduce the particulate

emissions into atmosphere.

• The wastewater generated from the plant will be about 31.31 KLD from process, washing,

utilities, DM regeneration, scrubber, Q.C, R&D and domestic wastewater.

• The effluent will be pumped to the above ground level R.C.C lined tanks for storage and

neutralization then sent to proposed ETP-ZLD of 40 KLD capacity within the premises.

• Domestic wastewater will be sent to ETP - ZLD.

• Hazardous waste will be segregated and collected in the HDPE drums / bags as appropriate

and will be stored in the covered and raised platform with provision of leachate collection

system.

• Solid waste like boiler ash will to be sent to cement brick manufacturers.

• Compressors, Boilers and DG sets will be the major noise generating units in the plant. Out

of these, the generator will be functioning at the time of power failure. Built-in acoustic

enclosures provided for D.G. set unit to minimize the noise levels. However the workers in

this area will be provided with ear muffs.

Industry is submitting Form-1 in MoEF&CC website, in the process of obtaining EC validity

extension for another 6 months to complete the implementation of the project. Hence, a technical

pre-feasibility report highlighting the project and the various operations including waste generation

and mitigation measures are prepared & submitted to the Environmental Appraisal Committee

(EAC).

2.0 Project Highlights

2.1 Identification of the Project and Project Proponent

M/s. Tejashrri Intermediates Pvt. Ltd. incorporated into Registrar of Companies on 06-01-

2005 had proposed to establish an APIs and intermediates manufacturing unit in 2007 and

obtained Environmental Clearance Vide F.No.J-11011/515/2007-IA II (I) dated 23-10-2007. Public

Hearing for the project was conducted by APPCB on 30-04-2007

• Owing to moratorium imposed by the then APPCB, there was delay in issuing Consent to

Establishment (CTE).


4

• CTE was later issued by APPCB vide order NO. 267/PCB/CFE/RO-NLG/HO/2011-2269

dated 24-10-2011.

• However industry could not implement the activity due to various issues as per EC & CTE.

By then EC validity was about to get expired.

• Application for EC Validity extension was submitted to MoEF vide letter dated 11-06-2012

Proposal for EC validity extension was considered in 3rd Reconstituted EAC meeting held

during 3rd – 5th December, 2012. EAC recommended for EC validity extension for another 5

years.

• However, signed EC extension validity was not received. Upon tracking in MoEF&CC

website, we were unable to trace the file (file No. J-11011/253/2012-IA.II (I)) and it was

shown as delisted.

• Resubmitted an application for EC validity extension on 01-12-2016 and validity of EC was

extended upto 22-10-2017 i.e. total 10 years vide letter No. J-11011/253/2012-IA-II (I) dated

15-02-2017.

• Now the industry is on verge of completing our project which requires maximum 3 to 4

months. As the validity of the EC is about get lapsed by 10 years and in order to complete

the implementation as per the permitted EC, application in Form-1 and PFR is being

submitted seeking extension of validity of EC to complete the implementation of the project.

• Industry proposes its implementation of EC permitted APIs and intermediates manufacturing

unit in the total area of 5.9488 Ha located at Sy. No. 94, Rahimkhanpet (V), Atmakur (M),

Yadadri Bhuvanagiri District (formerly Nalgonda District), Telangana State.

• Total investment for the proposed project is about Rs.4.85 Crores.

2.2 Brief Description of Nature of the Project

The project proponent proposes for extension of Environmental Clearance (EC) only as per

EIA Notification 2006, the project is 5 (f) Synthetic Organic Chemical Industry (Bulk Drug (API) &

Intermediates). The products manufactured are used in API formulation industry and the

therapeutic category of the products is Gastric antisecretory agent, Gastric Acid Secretion

Inhibitor, Antihistamine, Skeletal Muscle Relaxant, Decongestant, Antipsychotic Antidepressant

agent, Cardiovascular Agent, Antiasthmatic agent etc., which are applicable for human

consumption around the world after formulation activity.

The manufacturing process of APIs consists of chemical synthesis and multiple stage of

processing extending to maximum of ten stages involving different types of chemical reactions.

The entire process operations are operated by various technical, skilled and unskilled persons with

due care to be met various standards prescribed by authorities.


5

Technology for manufacturing the products listed under proposed project is available from

in-house R&D & private consultants and proposes to adopt new technologies and techniques that

are continuously refined in every stage of manufacturing to meet global standards. Industry will

implement the proven technologies in the R&D for the cost effective & environment friendly

practices.

2.3 Need for the Project and its Importance to the Country and or Region

The Indian pharmaceutical industry valued at $16 billion has portrayed tremendous

progress with reference to infrastructure development, technology base creation and a

wide range of production. India has achieved an eminent global position in pharma

sector. The Indian pharmaceuticals market is third largest in terms of volume and thirteen

largest in terms of value, as per a pharmaceuticals sector analysis report by equity master.

The market is dominated majorly by branded generics which constitute nearly 70% to 80%

of the market. The Indian pharmaceutical industry is estimated to grow at 20% compound

annual growth rate (CAGR) over the next five years, as per India Ratings. The domestic

pharma growth rate was 11.9% in October 2015.

It is estimated that by the year 2015, the Indian pharmaceutical industry has the potential to

achieve over Rs.2,00,000 Crore in formulations and bulk drug production. The industry now

produces bulk drugs belonging to all major therapeutic groups requiring complicated

manufacturing process and has also developed Good Manufacturing Practices (GMP)

facilities for the production of different dosage forms.

The pharma industry exports APIs and pharmaceuticals worth over $ 14.9 billion in 2013-

14. It ranks 17th in terms of export value of bulk activities and dosage. Indian exports cover

more than 200 countries including the highly regulated markets of USA, Europe, Japan and

Australia.

At a growth rate of 12% per year, the pharmaceutical industry in India is well set for rapid

expansion. As a result of the expansion, the Indian pharmaceutical and healthcare market

is undergoing a spurt of growth in its coverage, services, and spending in the public and

private sectors.

2.4 Demand and Supply Gap

The products manufacture by the proponent has demand from China, Japan, Middle East,

Latin American countries and other Asian countries etc. In addition, the products are consumed in

domestic market by Dr. Reddy labs, Mylan etc. It is reported that there is increase in the

consumption of these products by about 5-6% every year. As Indian industries are importing from

neighbouring countries and western countries, indicates the gap in the demand and supply of the

products in the domestic markets.


6

2.5 Imports vs. Indigenous production, Export Possibility, Domestic/Export Markets

Presently China is dominating in the API (bulk drug) market the world over. India is

importing all major intermediate chemicals required for manufacturing lifesaving drugs i.e., Anti-

Cancer Drugs, Anti ulcerative, etc. We are importing from China – the Third generation Antibiotics

mainly Cephalosporin intermediates that are of very high value. Most of our imports are from

Chinese companies and thus we are losing our valuable foreign reserves to China. As mentioned

above the imports have gone up from $ 2.9 billion in 2011 to about $ 4.6 billion in 2012 on account

of APIs, Pharmaceuticals and fine chemicals. During the same period the imports of formulations

has also doubled. The Chinese, American and European markets play a very vital role in the

supply of these products to our country. This clearly indicates that there is tremendous scope for

developing the indigenous products by reducing the imports and thus saving the foreign exchange

reserves of the country. This potential can be utilized to the fullest extent possible by increasing

the production capacity of the existing industries or by establishing new industries to meet the

market demand of the products.

As it is a well known fact that Indian products are well accepted abroad for its quality and

marketing flexibility. The exports from the Indian companies to other foreign countries such as

Europe, America, Japan and other African countries has been increasing from Rs.8007 in 2005 to

Rs.16565 Crores in 2009. This shows the acceptability of the products produced in India. The

formulations market has shown a tremendous increase in the exports from about Rs.9500 to

Rs.23700 Crores during the same period. However, the basic raw material for formulations is

APIs. Hence, this sector has a tremendous potential of indigenous market as well as export market

and the promotion of such projects will not only help by way of generation of employment but also

by generation of foreign currency reserves for the country. The figures mentioned above are

sourced from BDMA.

2.6 Employment Generation due to the Proposed Project

Direct employment will be about 62 persons and indirect employment will be about 35

persons from this proposed project. Thereby total employees will be 97 nos.

3.0 Project Description

3.1 Type of the project

Proposed project falls under category ‘A’ as per EIA Notification 2006 under the item No. 5

(f). There are no interlinked projects.

3.2 Location

The unit is located at Sy. No. 94, Rahimkhanpet (V), Atmakur (M), Yadadri Bhuvanagiri

District (formerly Nalgonda District), Telangana State. The proposed project site has coordinates


7

of all corners is presented in Table 1. The project site coordinates are 17°27'26.52"N and

79°12'11.46"E. The study area represents Rural Environment.

The map showing general location, specific location, Google map showing the project site

and plant layout of the total Project and existing project is enclosed at Annexures IX, X, XI & XII respectively.

3.3 Alternate sites

This proposed project is as per the permitted EC products in the existing plant area at

Rahimkhanpet village. Hence no alternate sites were considered.

Environmental considerations of this project site:

This proposed project is in existing industry land.

Human habitation is about 1.8 km (NNW) Rahimkhanpet village & 1.85 km (NE) to

Kapurayipally village

Water Bodies: • Bukleru river – 2.6 km (N) • Aleru river – 4.9 km (NE) • Virla cheruvu – 7.5 Km (WNW) • Pond near Rahimkhanpet – 2.2 km (NNW) • Pond near Paladugu – 5 Km (SE) • Pond near Sri Kanchanbhavi – 2.1 km (E)

There are no reserve forests.

Exist Transportation and Communication network There are no rare or endangered or endemic or threatened (REET) species of animals or birds.

3.4 Size or magnitude of operation Project Area: 5.9488 Ha. Production Capacity: 384 TPA from 3 out of 12 products at any

given point of time.

Products: The EC & CTE permitted products along with its production capacities are presented in

Table 1.

Table 1: Permitted Products as per EC & CTE and their Capacities

SI. No. Product Quantity Therapeutic Category (kg/day) (TPA)

1. Rabeprazole Sodium 66.67 24 Gastric antisecretory agent

2. Lansoprazole 66.67 24 Gastric Acid Secretion Inhibitor

3. Pantoprazole 66.67 24 Gastric Acid Secretion Inhibitor

4. Bromopheniramine 33.33 12 Antihistamine 5. Carisoprodol 333.33 120 Skeletal Muscle Relaxant 6. Phenylphrine Hydrochloride 400 144 Decongestant 7. Quetlapine Hemifumarate 33.33 12 Antipsychotic


8

8. Sertraline Hydrochloride 333.33 120 Antidepressant agent 9. Citalopram Hydrobromide 66.67 24 Antidepressant agent

10. Propranolol 66.67 24 Cardiovascular Agent 11. Aripiprazole 33.33 12 Antipsychotic 12. Oxatomide 33.33 12 Antiasthmatic agent Any 3 products on campaign basis out of 12 products at a time 1066.66 384

Source: M/s. Tejashrri Intermediates Pvt. Ltd. List of By-products

By-Product kg/day TPA Product Spent Sulfuric Acid 621.9 223.88 Rabeprazole Sodium,

Lansoprazole Hydrogen Bromide Sol. 1104.3 397.56 Phenylephrine Hydrochloride,

Aripiprazole 3.5 Project Description with Process Details

The manufacturing process of APIs consists of chemical synthesis extending to maximum

of 10 stages of processing involving different types of chemical reactions. Typical process

description with process details is enclosed at Annexure-XIII. These drugs are mainly used for

human medication after formulation activity for various diseases. Industry will implement the

proven technologies in the R&D for the cost effective & environment friendly practices. The plant

layout showing proposed components of the project is enclosed at Annexure-XI.

3.6 Raw Materials

The raw materials required for the manufacture of proposed products are the chemicals

and the fuel.

• The APIs manufacturing involve the use of various chemicals and organic solvents either

directly as reactant or for extraction of a product of interest from the reaction mixture.

• Coal consumption will be 8 TPD for the EC & CTE permitted 2 TPH coal fired boiler.

• Diesel of about 69 lit/hr will be used in the EC & CTE permitted 2x125 KVA and 2 lakh

Kcal/hr Diesel Thermic Fluid Heater.

• The total power requirement of the proposed plant is 250 HP.

• Mode of transportation of all raw materials and finished products from the project site is by

road to local markets and by road / rail / sea if exported.

The chemicals (raw materials) required for the manufacture of proposed products is

presented at Annexure – XIV and Hazardous chemicals list is presented at Annexure – XV.

3.7 Resources Optimization / Recycling and Reuse

Following are some of the recycle options proposed by the industry.

Improvement of yield of the products so as to reduce the waste generation during

manufacturing.


9

Industry is proposing for Zero liquid discharge plant to reuse all treated effluents as makeup

water for utilities like Cooling Tower. This will reduce the fresh water consumption.

All solvents are recovered to the extent possible and reused in the process.

Organic residue and spent carbon will be sent to Authorized Cement industries to burn in

Cement Kiln as an alternate fuel.

Boiler ash will be sent to Cement Brick manufacturing units.

Waste / Used oil will be sent to Authorized Waste / Used oil Reprocessing units.

Container & container liners of hazardous chemicals, Polythene / HDPE Bags, broken plastic

drums shall be disposed of to outside agencies after complete detoxification.

Spent catalyst will be sent back to supplies

Waste Lead acid batteries will be sent back to suppliers on buy back basis.

Optimum utilization of solar energy.

Recycling and reuse of by-products, solvents generated during the process will also be

planned properly thereby implementing the clean manufacturing techniques.

3.8 Availability of Water and Energy

The total water requirement is about 62.12 KLD which will be met from Groundwater from

existing bore well. The proposal is to minimize the effect on the level of water table by practicing

reuse / recycling of the treated water wherever possible thereby reducing the fresh water re-

quirement.

The total power requirement will be met from Telangana State Power Distribution

Corporation Limited (TSPDCL). Coal and Diesel will be procured from the distribution sources

closer to the project site.

3.9 Quantity of Wastes Generation and their Management/ Disposal

3.9.1 Water requirement and Wastewater Generation and their Management/ Disposal

The water requirement and wastewater generation with its proposed treatment is presented

in Table 2 & 3 respectively. The sources of wastewater generation are from the process, floor &

reactor washes, utilities, Q.C, R&D, scrubber and plant domestic waste. Total proposed

wastewater will be 31.31 KLD, which will be segregated into HTDS/HCOD & LTDS/LCOD and

collected by gravity into a collection tank separately. This individual effluent will be pumped to the

above ground level R.C.C lined tanks for storage and neutralization then sent to ETP-ZLD.


10

Table 2: Water Balance, Segregation and Treatment Method

Description Water Input (KLD)

Wastewater (KLD)

Segregation type of Wastewater

Process (3 products at a time) 18.92 20.81 HTDS/HCOD

Washings (reactor,centrifuges, containers, floor mopping, etc.,)

2 2 LTDS/LCOD

Boiler

30 2.5

Utilities (LTDS/LCOD)

Cooling Tower

DM Regeneration HTDS / LCOD

Scrubber & Q.C 2 2 HTDS / LCOD R&D 1 1 LTDS/LCOD Domestic 3.2 3 LTDS/LCOD Greenbelt 5 - --

Total 62.12 31.31

Note: 19.84 KLD is 20.81 Tons consists of 19.84 KLD liquid effluent and 0.97 Tons of salts (Max. on various combinations) as per material balance.

Table 3: Effluent Treatment Flow for as per Segregation

Effluent Characteristics

Quantity (KLD) Treatment Flow

Process, DM & Scrubber

HTDS/HCOD & (HTDS)

HTDS > 5000 mg/l HCOD > 5000 mg/l

22.81

Collection Equalization Neutralization Settling Holding Steam stripper MEE along with HTDS effluent Condensate to ETP (biological treatment) Concentrate to ATFD ATFD Condensate to ETP (Biological Treatment) along with domestic wastewater (septic tank overflow) Pressure Sand Filter Activated Carbon Filter R.O R.O rejects to MEE. R.O Permeate & MEE Condensate to cooling tower ATFD Salts to TSDF and stripped solvents to SPCB authorized cement industries

Washings, Boiler, Cooling Tower, QC &

R&D LTDS / LCOD

LTDS < 5000 mg/l LCOD < 5000 mg/l

5.5 Collection Equalization Neutralization ETP (Biological Treatment) along with MEE Condensate

Domestic 3 Collection Tank sent to ETP (Biological Treatment) along with LTDS / LCOD Effluent


11

Proposed the Effluent Treatment Plant system (ETP) capacity of 40 KLD and flow chart is

enclosed as Annexure-XVI. All the treatment tanks etc., will be constructed / installed above the

ground with water proof lining. This individual effluent will be pumped to the above ground level

R.C.C lined tanks for storage and neutralization then sent to ETP-ZLD.

ETP-ZLD facility consists of primary (equalization and neutralization), secondary (stripper

with MEE, ATFD & biological) and tertiary treatment (PSF, ACF & R.O) will be provided. Domestic

wastewater will be sent to collection tank and then to ETP (biological treatment) along with

LTDS/LCOD. Concentrate from MEE system will be sent to ATFD and the salts from the

evaporation system will be collected and sent to TSDF for safe disposal.

3.9.2 Hazardous / Solid Waste Generation, Handling and their Disposal

Hazardous/ Solid waste will be segregated, detoxified and collected in the HDPE Drums /

Bags and will be stored in the covered and raised platform with Leachate collection system. The

proposed solid waste and other waste generated, handling and disposal method from the various

stages of manufacturing plant is presented in the Table 4. Spillages such as wastewater / solid

wastes / raw material are possible and the risk of this would be limited to within the premises of the

manufacturing facility. A precautionary measure like spillage control management is practiced in

the industry.

Table 4: Hazardous / Solid Waste Generation from the Proposed Products

Sl. No. Source

*Proposed Quantity

(TPD) Handling Method Disposal

1. Organic residue 2.51 HDPE Drums

Sent to SPCB Authorized Cement industries (or) to

TSDF for Incineration 2. Spent Carbon 0.097

3. Inorganic & Evaporation salt (Process) 0.78 HDPE Bags

Sent to TSDF for Landfill (or) Incineration (or) to SPCB

Authorized Cement industries 4. ETP Sludge 0.02

5. Boiler Ash 3.2 Stored in covered area

Sold to Cement Brick Manufacturers

* Solid waste quantities maximum on 3 products at a point of time

3.10 Schematic Flow Sheet for EIA Procedure

The schematic flow sheet for EIA procedure is depicted as Annexure -.XVII.

4.0 Site Analysis

4.1 Connectivity

The project site is at 00.25 km (N) to road connecting Mothkur and Rayagiri villages which

further connects to National Highway – 163 (previously NH-202), 1.8 km (NNW) to nearest village

Rahimkhanpet village & 1.85 km (NE) to Kapraipalli village, 7 km (W) to Atmakur village, 56 km


12

(W) to Hyderabad ORR, 23 km (SW) to Valigonda Railway Station & 27 km (NW) to Wangapally

Railway station and 82 km (SW) to Rajiv Gandhi International Airport, Hyderabad.

4.2 Land Form, Land use and Land Ownership

Total land is 5.9488 Ha. is in possession of Project Proponent.

4.3 Topography

The Topography map with a 10 km radius is enclosed as Annexure-XVIII.

4.4 Existing Land Use Pattern

The land use pattern of project area (core area) 5.9488 Ha. Industrial land and shortest

distance of environmental components in buffer area from the project periphery is given in Table 5.

Table 5: Environmental Components Shortest distance from Project Periphery

S. No. Particulars Details (Distance & Direction w.r.t. site)

1. Water bodies • Bukleru river – 2.6 km (N) • Aleru river – 4.9 km (NE) • Virla cheruvu – 7.5 Km (WNW) • Pond near Rahimkhanpet – 2.2 km (NNW) • Pond near Paladugu – 5 Km (SE) • Pond near Sri Kanchanbhavi – 2.1 km (E)

2. Reserve Forests Nil 3. National Parks/ Wild

Life Sanctuaries/ Eco sensitive areas

Nil

4. Habitation 1.8 km (NNW) to Rahimkhanpet village & 1.85 km (NE) to Kapurayipally village

1.5 Existing Infrastructure National Highway, road network, transportation facilities, water supply, Power supply,

Conference hall, Telecommunication facility etc., are available.

1.6 Soil Classification

The soil in the project site is red and brown in colour with silty clay texture.

4.7 Climate Data from Secondary Sources

The project area comes under the Deccan Plateau of vast triangular platform of peninsular

shield, which is the most distinctive physiographic unit of India. The area is represented by

undulating topography marked by scattered hillocks, domes, ridges, Irregularities of land are also

operations to assess the environmental quality frequently observed. The area enjoys pleasant, warm and dry climate. The coldest season is during December and


13

January, where the temperature touch a minimum of 12-16°C and warmest period is during the

month of April to May when the Mercury shoots up to 43 - 46 °C. The area experiences the maximum rainfall during the months of June to September and a little

rainfall during October and November due to North-East monsoon. Apart from these, occasional

rainfall is obtained from cyclonic storms and depression originating in the Bay of Bengal. The

average annual rainfall of the area is 786 mm. The rainfall is erratic and long period of dry spells

leading to drought conditions are frequent and periodic. The relative humidity ranges between 75-

95% during monsoon and 35-40% in summer afternoon.

4.8 Social Infrastructure

0.25 km (N) to road connecting Mothkur and Rayagiri villages which further connects to

National Highway – 163 (previously NH-202), road network, transportation facilities, power supply,

fire station and other basic amenities such as telecommunication facility, education centre,

hospitals, community halls are available at Atmakur village at 7 km (W).

5.0 Planning

5.1 Planning Concept

Type of Industry: The project (EC & CTE permitted) is within the EC permitted premises for the

production of APIs & intermediates Manufacturing Unit.

Facilities: Industry proposed its API manufacturing unit at existing land and facilities required for

the project will be provided as per requirement.

Transportation: Transportation of raw material and final products is done via roads as the

proposed project is well connected with roads, rail and airways.

Town and Country Planning Classification: Industry land is private land converted to industrial

use and is in possession of project proponent.

5.2 Population Projection

There is a scope for increase in the population from the proposed project. Skilled workers

prefer to stay in the nearby locations to avoid travelling from long distances. Local non-technical

villagers will be preferred for the unskilled jobs such as gardening, movement of materials, etc.

Local / Non local educated youth will be employed as semi-skilled workers and training will be

provided. Hence, there is a possibility of increase in population of the skilled and semi-skilled.

However, on the whole there is a possibility of little increase in population of the area.

5.3 Land use Planning

The unit has been proposed in the existing land. Land use pattern of the project area is

given in Table 6.


14

Table 6: Land Breakup Details

S. No.

Purpose

Area % Sq.m 1. Built up area 3330 5.6 2. Green belt 30000 50.4 3. Open area 22658 38.1 4. Roads 3500 5.9

Total 59488 100

5.4 Assessment of Infrastructure Demand

On assessment of infrastructure demand near the project area Hospital with Ambulance

facility and Fire station is requirement for the nearby villages of project area.

5.5 Amenities/Facilities

Industry will provide the following amenities / facilities in the proposed project.

• Canteen • Potable drinking water • Training block • Laying of Black top / Concrete internal roads • Fire hydrant facility • Eye/body wash showers • First Aid kits at all prominent places. • Head nurse for emergency medication. • Rest Room for employees • Seating facilities for those employees who do their work standing and ergonomically

designed sitting facilities for those who do their work sitting • Pre-employment and routine medical examinations and the necessary follow up actions • Communication systems like Phone, Internet with safety measures, etc. • Security system at the entrance etc.

6.0 Proposed Infrastructure

6.1 Industrial Area

Production blocks, administration facilities, utility area, ETP area are been proposed in the

area.

6.2 Residential Area :

There will be no residential area within the project site.

6.3 Greenbelt

The unit has been proposed in an area about 5.9488 Ha i.e., 59488 sq.m. Out of which

about 3 Ha i.e. 30000 sq.m is allocated for greenbelt area which is equivalent to 50% of the total

area.


15

6.4 Social Infrastructure

As a Corporate / Entrepreneur Social Responsibility (ESR), Industry will contribute for

development of village social infrastructure.

6.5 Connectivity

There is no change in connectivity compare to existing facility.

6.6 Drinking Water Management

Potable drinking water will be provided to all employees. The source of drinking water is

Groundwater.

6.7 Sewerage System

Sewage will be generated from the Canteen and Toilets, which will be collected into

sewage collection tank through pipelines and will be sent to ETP – ZLD system.

6.8 Industrial Waste Management

API manufacturing industry generally contributes to all types of waste such as liquid, solid

and gaseous. The management of these wastes is to be handled very sensitively and by adopting

proper segregation techniques.

Liquid Waste Management: The liquid wastes from the various industrial activities will continue to

be segregated and send to ETP-ZLD.

Process Emissions Management:

Manufacturing of APIs will result in gaseous emissions. Maximum Process emissions from

proposed products are given in Table 7. Proposed gaseous emissions will be scrubbed in two

stage scrubbers with water or other liquid based on the characteristics of gases.

Table 7: Maximum Quantity of Process Emission for Proposed Products

Sl. No.

Process Emission

Maximum Quantity on various combinations

(kg/day) Treatment Method

1. HCl 54.26 Scrubber with water / caustic sol. 2. H2 35.2 Diffused with flame arrestor 3. SO2 42.47 Scrubber using caustic sol. 4. NH3 11.6 Scrubber with water 5. CO2 36.54 Dispersed into atmosphere

Fugitive emissions Management:

Solvents used in the APIs manufacturing process will be stored in drums and bulk

quantities will be stored in underground/ above ground storage tanks.


16

Solvents are handled in closed conditions thereby reducing the losses in the form of

evaporation.

Proper earthing will be provided to all the electrical equipment and the joints / connections

wherever solvent handling is done.

Reactor and solvent handling pump will have mechanical seals to prevent leakage.

The industry will take measures for reduction of fugitive emissions and for further reduction

industry will provide vent condensers to the tanks.

Chilled brine circulation will be carried out to condensate the solvent vapour and to the

receivers of the solvent vapors which ensures the maximum recovery.

Solvent vapours from the Centrifuge and Catch pots will be connected to vent condensers.

The height of the solvent receiver tank vent is above production block roof level and the

diameter is 20 mm.

Flame proof fitting / equipments / pumps / lighting will be used wherever solvents are used.

The solvent storage tanks will be provided with breather valve to prevent losses.

Solvent Input Solvent

Solvent Recovery

Solvent Recovery In Effluent In Org.

residue Loss

(Evaporation) (KLD) (KLD) (KLD) (KLD) (KLD) (%) 43.89 0.28 0.38 1.69 41.27 94

Emissions from Utilities Management:

Boilers and DG sets are the two main sources contributing to emissions from the plant. EC

& CTE permitted coal fired boiler is 2 TPH. Diesel will be used for EC & CTE permitted 2 lakh

Kcal./hr TFH and 2 x125 KVA. DG Sets will be used as standby power during power failures. The

emissions from the boiler are given in Table 8.

Table 8: Stack Emission Details

Source Stack Height

(m) Diameter

(m) Temperature

( oC)

Flue Gas Flow rate

(m3/hr)

Exit Gas Velocity (m/sec)

PM SO2 NOx

kg/hr

Coal fired Boiler 2 TPH 30 0.4 150 5323 11.8 0.27 2.83 1.62

Diesel fired thermic fuel heater 2 lakh Kcal/hr 30 0.2 150 868 7.68 0.004 0.088 0.094

DG Sets 125 KVA 7 0.1 150 706 24.9 0.008 0.16 0.17 125 KVA 7 0.1 150 706 24.9 0.008 0.16 0.17

The various measures proposed to minimize the pollution from the boiler are as follows:


17

Multi-cyclone separator followed by Bag filter will be installed to control the particulate (PM)

emissions within statutory limit of 115 mg/Nm3. To facilitate wider dispersion of pollutants,

30m height stack each will be installed.

The NOx emissions from the boilers will be controlled by controlling combustion measures,

which will be approached by way of low NOx burners or by air stagging in boiler. The NOx

emissions will be restricted to below 500 mg/Nm3.

Stacks will be provided to D.G sets as per CPCB / SPCB Guidelines.

Fugitive dust will be controlled by adopting dust extraction and dust suppression measures

and development of greenbelt along the periphery of the Boiler area.

Noise Management:

• Compressors, Boilers and DG sets will be the major noise generating units in the plant.

• The noise levels of the DG sets will be well within the limits as these will be installed with acoustic enclosures. Workers will always be provided with ear muffs.

• All the equipment in the plant would be designed to have a total noise level not exceeding

85-90 dB(A) as per the requirement of OSHA (Occupational Safety and Health

Administration) standards.

6.9 Hazardous / Solid Waste Management

• Solid waste mainly segregated into process organic residues, inorganic salts, boiler ash

spent mixed unrecoverable solvents and spent carbon.

• The organic residues, Spent carbon & Spent mixed unrecoverable solvents can be

disposed off to Cement plants as recommended by CPCB for use as alternate fuels either

in the solid or liquid form.

• Boiler ash will be sold to brick manufacturers.

• Inorganic salts are to be sent for landfill at TSDF.

Solid waste will be segregated, stored and disposed as mentioned in the Table 5.

6.10 Power Requirement & Supply / Source

Power supply 250 HP will be drawn from the nearby sub-station of TSPDC. D.G. set will be

used as alternate arrangement in case of failure in power supply. EC & CTE permitted 2 x 125

KVA.

7.0 Rehabilitation and Resettlement (R&R) Plan

The proposed project is in the EC permitted land and is in possession of project proponent.

Therefore Rehabilitation and Resettlement plan is not applicable to this project. The nearest

habitation is away from more than 1 km from the project site.


18

8.0 Project Schedule & Cost Estimates

8.1 Time Schedule for the project construction

The timelines for commencement of proposed operation will be from April 2018 as it is

expected that the project will be in a position to obtain Environmental Clearance & Consent for

Operation for the project. In April 2018 the commercial production is expected to be commenced.

8.2 Estimated project cost

Overall estimated cost involved in the total project like land, building, plant & machinery is

Rs. 4.85 Crores. Total capital cost allocated towards environmental pollution control measures is

Rs. 50 lakhs and the Recurring cost will be about Rs. 10 lakhs per annum.

9.0 Analysis of proposal (Final Recommendations)

• The proposed project will result in growth of surrounding area by generating direct and

indirect employment to local people. Around 97 members will be benefitted due to the

project.

• Under the Enterprise Social Commitment (ESC) the Industry will develop a policy of

developing the villages in the vicinity by identifying the requirements.

• No adverse effect on environment is envisaged as proper mitigation measures will be taken

up.

• Industry will strengthen the Safety, Health & Environment Department and engage

recognized laboratories to carry out all necessary monitoring parameters for its activities.

• The segregated (HTDS / LTDS) wastewater will be regularly analyzed before and after

treatment in ETP-ZLD.

• Qualified staff will be appointed for the purpose of Operation and Maintenance of the

pollution control facilities.

• Stand-by facilities will be provided to all the pumps so as to ensure fail proof treatment,

handling and disposal.

9.1 Budgetary allocation for Pollution Control Measures

The management will set aside adequate funds in its budget to fully meet the stated

objectives of the environmental policy. The proposed capital equipment for environmental

management include effluent treatment plants, pipelines and channels for wastewater discharge,

greenbelt development, environment laboratory, fire, occupational health etc.

Annexures

ANNEXURE - I

19

ANNEXURE - II

20

ANNEXURE - II

21

ANNEXURE - II

22

ANNEXURE - II

23

ANNEXURE - II

24

ANNEXURE - III

25

ANNEXURE - III

26

ANNEXURE - III

27

ANNEXURE - III

28

ANNEXURE - III

29

ANNEXURE - III

30

ANNEXURE - III

31

ANNEXURE - III

32

ANNEXURE - III

33

ANNEXURE - IV

34

ANNEXURE - IV

35

ANNEXURE - IV

36

ANNEXURE - IV

37

ANNEXURE - IV

38

ANNEXURE - IV

39

ANNEXURE - IV

40

ANNEXURE - IV

41

ANNEXURE - V

42

ANNEXURE - VI

43

ANNEXURE - VI

44

Ministry of Environment,Forest and Climate Change Government of India

Online Submission & Monitoring of Environmental Clearances

Environment Clearance Other Status Query Form

Industrial Projects1

Home Services Blog Contact Us

* Category: Year : All Years

* Status : Delisted State : All State

Enter text for Search : IA/AP/IND/3732/2012

SEARCH

List of the proposals as per above given/selected query (As on 01‐12‐2016)

Help : * Kindly click on image button to open the attached files .

S.No Proposal Details Location Important Dates Category Company/Proponent * Attached Files

1

Proposal No : IA/AP/IND/3732/2012

File No : J‐11011/253/2012‐IA.II(I)

ProposalName : Drug

State : AndhraPradesh

District : Nalgonda

Village : RahimKhanpet

Date of Receipt forProposal : 19 Jun

2012

Date of Delisted : 01 Jan2013

IndustrialProjects‐1

M/s TejashrriLaboratories Pvt. Ltd.

ANNEXURE - VII

45

http://environmentclearance.nic.in/writereaddata/Others/DList/0_0_26_May_2014_1221382301NewMicrosoftWordDocument.pdf

http://environmentclearance.nic.in/Default.aspx

http://environmentclearance.nic.in/Contactus.aspx

ANNEXURE - VIII

46

ANNEXURE - VIII

47

Project Site Location Map

1

M/s. Tejashrri Intermediates Pvt. Ltd.

Telangana state

Rahimkhanpet (V), Atmakur (M), Yadadri District

ANNEXURE - IX

48

Villages

Specific Location (Route Map)


RaheemKhanpet

RaheemKhanpet Bus Stop

Khapuraayipally Raigiri–Mothkur Road

Kurella

Panakabanda Bus Stop


Atmakur (M)

ANNEXURE - X

49

Google Map Showing Project Site

ANNEXURE - XI

50

ANNEXURE - XII

51

Description:

Stage-4 compound is reacted with Sodium Hypochlorite to get Rabeprazole Compound.

Stage 3 compound is reacted with Thionyl chloride and further reacted with 2-Mercapto Benzimidazole to getStage-4 Compound.

Stage-5 (Rabeprazole) compound is reacted with Sodium Hydroxide to get Rabeprazole Sodium.

Stage 2 compound is reacted with Acetic Anhydride, Sodium hydroxide and Hydrochloric acid to get Stage-3Compound.

4-Nitro-2,3-Dimethyl Pyridine-N-Oxide is reacted with 3-Methoxy-1-Propanol and Sodium hydroxide to getStage-2 Compound.

2,3-Lutidine is reacted with Hydrogen Peroxide in presence of Acetic Acid to give N-oxide it further reacts withNitration mixture (Nitric Acid+Sulfuric Acid) to give (Stage-1) 4-Nitro-2,3-Dimethyl Pyridine-N-Oxide

PRODUCT : Rabeprazole Sodium

ANNEXURE - XIII

52

Flow Chart:

2,3-LutidineAcetic acid Sol.RecoveryHydrogen peroxide(50%) Evaporation LossSulfuric Acid Send to Auth. PartyNitric AcidWater

4-Nitro-2,3-Dimethyl Pyridine-N-Oxide Sol.Recovery3-Methoxy-1-Propanol Evaporation LossSodium HydroxideTolueneDMSO

Stage-2 Sol.RecoveryAcetic Anhydride Evaporation lossSodium Hydroxide EffluentHydrogen Chloride gas Organic ResidueTolueneWater

Stage-3Thionyl Chloride Sol.RecoveryToluene Evaporation Loss2-Mercapto Benzimidazole EffluentSodium Hydroxide Organic ResidueWater Process Emissions

Stage-4Sodium Hypochlorite(4%) Sol.RecoveryMethylene Dichloride Evaporation Lossn-Hexane Effluent

Organic Residue

Rabeprazole Base Sol.RecoverySodium Hydroxide Evaporation LossIsopropyl Alcohol Organic ResidueCarbon Spent Carbon

PRODUCT : Rabeprazole Sodium

Organic Residue

Rabeprazole Sodium

Inorganic Solid Waste

Stage II

Stage III

Stage IV

Stage V

Stage-VI

Stage I

ANNEXURE - XIII

53

Description:

PRODUCT : Lansoprazole

Stage-4 Compound is reacted with Hydrogen Peroxide in presence of Isopropyl Alcohol, Chloroforma nd Acetone to get Lansoprazole.

2,3-Lutidine is reacted with Hydrogen Peroxide and Nitric Acid in presence of Acetic Acid to get Stage-1Compound.

Stage-1 Compound is reacted with Trifluoro Ethanol, Potassium Carbonate, Acetic Anhydride. SodiumHydroxide and Hydrochloric Acid in presence of MIBK and Toluene to get Stage-2 Compound.

Stage-2 Compound is reacted with Thionyl Chloride in presence of Toluene and Methylene Dichloride to get Stage-3 Compound.

Stage-3 Compound is reacted with 2-Mercapto Benzimidazole and Sodium Hydroxide to get Stage-4 Compound.

ANNEXURE - XIII

54

Flow Chart:

2,3-LutidineAcetic acid Sol.RecoveryHydrogen peroxide(50%) Evaporation LossSulfuric Acid Send to Auth. PartyNitric AcidWater

Lansoprazole NitroSodium Hydroxide Sol.RecoveryPotassium Carbonate Evaporation LossTri Fluoro Ethanol EffluentMIBK Organic ResidueAcetic Anhydride Spent CarbonTEBACTolueneHydrochloric Acid gasActivated CarbonWater

Hydroxy Methyl HydrochlorideMethylene Dichloride Sol.RecoveryToluene Evaporation LossThionyl Chloride Organic residue

Process Emissions

Lansoprazole Chloro2-Mercapto Benzimidazole EffluentSodium Hydroxide Organic residueWater

Lansoprazole sulphideIsopropyl Alcohol Sol.RecoveryHydrogen Peroxide (50%) Evaporation LossCatalyst EffluentChloroform Organic ResidueAcetoneSodium HydroxideAcetic AcidWater


Lansoprazole

Stage II

Stage III

Stage IV

Stage V

Stage I

ANNEXURE - XIII

55

PRODUCT : Pantoprazole

Stage-8 compound is reacted with (5-Difluoromethoxy)-2-mercapto Benzimidazole and Sodium Hydroxide in presence of Toluene to get Stage-9 Compound.

Stage-9 Compound is reacted with Sodium Hypochlorite to get Pantoprazole.

Stage 1 compound is reacted with Ammonium Carbonate in presence of Toluene to get Stage-2 Compound.

Stage 2 compound is reacted with Phosphorus Oxychloride in presence of Ethylene Dichloride to get (Stage-3)compound

Description :

Maltol is reacted with Diemthyl Sulfate in presence of Potassium Carbonate in Acetone solvent media to get (Stage-1) Compound.

Stage-3 compound is reacted with Hydrogen Peroxide in presence of Methylene Dichloride and n-Hexane to get Stage-4 Compound.

Stage-4 compound is reacted with Sodium Methoxide in presence of Methanol to get Stage-5 Compound.

Stage-5 compound is reacted with Acetic Anhydride to get Stage-6 Compound.

Stage-6 compound is reacted with Sodium Hydroxide in presence of Methylene Dichloride to get Stage-7 Compound.

Stage-7 compound is reacted with Thionyl Chloride in presence of Toluene and Acetone to get Stage-8 Compound.

ANNEXURE - XIII

56

Flow ChartMaltolDimethyl Sulfate Sol.RecoveryPotassium carbonate Evaporation LossAcetone Organic Residue

Inorganic Solid WasteProcess Emissions

Stage-1 Sol.RecoveryAmmonium carbonate Evaporation LossWater EffluentToluene Organic Residue

Process Emissions

Stage-2Phosphorus oxychloride Sol.RecoveryWater Evaporation LossSodium hydroxide EffluentEthylene dichloride Organic Residue

Stage-3Hydrogen peroxide (50%) Sol.RecoveryAcetic acid Evaporation LossSodium hydroxide EffluentWater Organic ResidueMethylene dichloriden-Hexane

Stage-4Sodium Methoxide Sol.RecoveryMethanol Evaporation Loss

Organic ResidueInorganic Solid Waste

PRODUCT : Pantoprazole

Stage I

Stage II

Stage III

Stage IV

Stage V

ANNEXURE - XIII

57

Stage-5 Sol.RecoveryAcetic anhydride Evaporation Loss

Organic Residue

Stage-6 Sol.RecoverySodium Hydroxide Evaporation LossMethylene dichloride EffluentWater Organic Residue

Stage-7Thionyl chloride Sol.RecoveryToluene Evaporation LossAcetone Organic Residue

Process Emissions

Stage-8Sol.Recovery

Evaporation LossSodium Hydroxide EffluentWater Organic ResidueToluene

Stage-9Sodium Hypochlorite EffluentWater Organic ResidueCarbon Spent Carbon

5-Difluoromethoxy-2-mercapto benzimidazole

Pantoprazole

PRODUCT : Pantoprazole Stage VI

Stage VII

Stage VIII

Stage IX

Stage X

ANNEXURE - XIII

58

Stage-1

Stage-4

PRODUCT : Brompheniramine

In the second stage stage-1 is mixed with toluene, and slowly add sodamide for half an hour and then add 2-Chloropyridine into the reactor. Slowly raise the temp to at 60-65oC. Maintain the temp for about 2-3hrs.Toluene is added to the reaction mass and then water is added. Extracted with toluene and on distillation gives4-Bromophenyl-2-Pyridinyl acetonitrile product.Then cooled to 10-15oC and centrifuged then unload the massinto carboys.

Stage-3

In the third stage take stage-2 and 2,(dimethyl amino) ethyl chloride at 40-45oC Stir for 1/2 hr and add sodamide at 40-45oC. Stir for 4-5 hours. After reaction is completed by fractional distillation collect Bromophenyl-4-dimethylamino-2-Piridinyl acetonitrile Product 55oC.

Description :

Phenyl acetonitrile is taken in GLR, slowly add bromine at 45oC then slowly raise the temperature to 65-70oC and maintain for about 4-6 hours and PH adjust with Sodium Hydroxide liberates Sodium Bromide slowly raise the temperature to 80-85oC and on fractionation gives the P-Bromo pheny acetonitrile product.

In the fourth stage charge stage-3 and Sodium Methoxide in Methanol at 0-5oC check the PH it should be around 2-2.4 maintain the same conditions for about 2 hours to get the Brompheniramine Product.

Stage-2

ANNEXURE - XIII

59

Flow Chart

Phenyl acetonitrileToluene Sol.RecoveryBromine Evaporation LossSodium Hydroxide EffluentWater Organic Residue

Stage-12-Chloro Pyridine Sol.RecoverySodamide Evaporation LossToluene EffluentWater Organic Residue

Process Emissions

Stage-22-(Dimethylamine)ethylchloride EffluentSodamide Organic ResidueWater Process Emissions

Stage-3Sodium Methoxide Sol.RecoveryMethanol Evaporation LossWater Effluent

Organic Residue

Brompheniramine


Stage I

Stage II

Stage III

Stage IV

ANNEXURE - XIII

60

Stage-II:

Stage-III

Stage-IV:

Flow Chart

Sol.RecoveryDimethyl carbonate Evaporation LossSodium Methoxide Organic ResidueToluene

Stage-1Isopropylamine Sol.Recovery

Evaporation Loss

Stage-2Chloroform Sol.RecoverySodium Cyanate Evaporation LossHydrochloric Acid gas EffluentToluene Organic ResidueWater Spent CarbonActivated Carbon Process Emissions

Carisoprodol (crude) Sol.RecoveryMethanol Evaporation LossWater EffluentActivated Carbon Organic Residue

Spent Carbon

Stage-I:

Description :

2-Methyl-2-propyl-propane-1,3-diol [MPD] is reacted with Di methyl carbonate [DMC] in presence of Sodium methoxide as a Base in Toluene solvent medium followed by high vacuum distillation to produce Stage-I material.

PRODUCT : Carisoprodol

Stage-I is reacted with Isopropyl amine under pressure conditions to produce Stage-II material.

Stage-II is reacted with Sodium cyanate in Acidic conditions (HCl gas) followed by isolation in Toluene to produce crude carisoprodol (Stage-III).

Crude on Carbon treatment & recrystalization in Aqueous Methanol medium to produce pure Carisoprodol.

2-Methyl-2-Propyl Propane-1,3-diol

Carisoprodol

Stage I

Stage II

Stage III

Stage IV

ANNEXURE - XIII

61

Stage-1

Stage-2

Stage-3

Flow Chart

3-Hydroxy AcetophenoneBromine Sol.RecoveryAIBN Evaporation Loss1,4-Dioxane Send to Auth. PartyToluene Organic ResidueSodium Sulfate Inorganic Solid WasteWater

Stage-1 Sol.RecoveryN-Methyl benzylamine Evaporation Loss

Send to Auth. PartyOrganic Residue

Water Process Emissions

Stage-2Methanol Sol.RecoveryHydrogen Evaporation LossPalladium Carbon Organic ResidueCarbon Spent Carbon

Process Emissions

Phenylephrine Hydrochloride

Isopropyl Alcohol Hydrochloride (20%)

Take AIBN add 3-hyroxy acetophenone and 1,4-dioxane. Check the dissolution, heat to reflux (78-80oC) under reflux add bromine slowly, maintain reflux for 8 hrs. Check the GC for starting material it should not be more than 1% Distill 1,4-dioxane then collect stage-1 by fractional distillation under high vaccum.

Take stage-1 and then add N-Methyl benzylamine to that add IPA HCl at 50oC temperature. Then slowly rise the temperature to 55-60oC close the man hole under self pressure the pressure raises to 2 kgs maintain at this pressure for 4 hrs. Check TLC for starting matrial it should be nill. Cool the mass to RT distill off IPA 3/4 of the starting material cool to RT. Maintain at RT for about 30 mins and then centrifuge the material.

To the stage-2 add methanol and 10% PD Catalysat heat to 40-45oC maintain at pressure 2.5 Kg under hydrogen gas passing, maintain for 8 hrs. Check TLC, if TLC complies filter off Pd catalyst. Distill off methanol. Cool to 5oC then Centrifuge the material.

Description :PRODUCT : Phenylephrine Hydrochloride

Stage I

Stage II

Stage III

ANNEXURE - XIII

62

Stage : 1

Stage : 2

Flow Chart

11-Piperazin dibenzo[b,f] [1,4] Thiazepine dihydrochloride Sol.RecoverySodium Carbonate Evaporation Loss2-Chloroethoxy Ethanol EffluentIsopropyl Alcohol Organic ResidueEthyl Acetate Process EmissionsWater

Quetiapine Sol.RecoveryFumaric acid Evaporation LossIsopropyl Alcohol Organic ResidueCarbon Spent Carbon

11-Piperazin dibenzo[b,f] [1,4] Thiazepine dihydrochloride is reacted with 2-Chloroethoxy Ethanol and Sodium Carbonate in presence of Isopropyl Alcohol and Ethyl Acetate to get Quetiapine.

Quetiapine Hemifumarate

Description :

PRODUCT : Quetiapine Hemifumarate

Quetiapine is reacted with Fumaric Acid in presence of Isopropyl Alcohol to get QuetiapineHemifumarate.

Stage I

Stage II

ANNEXURE - XIII

63

Flow Chart

TetraloneMethanol Sol.Recovery

Evaporation LossOrganic Residue

Stage-IMethanol Sol.RecoverySodium Borohydride Evaporation LossHydrochloric Acid(35%) EffluentWater Organic Residue

Stage-IIEthyl Acetate Sol.RecoveryAmmonia solution(18%) Evaporation LossMandelic acid EffluentEthanol Organic ResidueWater

Stage-IIIEthyl Acetate Sol.RecoverySodium Hydroxide Evaporation LossActivated Carbon EffluentWater Organic ResidueHydrochloric Acid (35%) Spent CarbonHyflo

Sertraline Hydrochloride

The Pure Sertraline Mandelate salt is neutralized with Sodium Hydroxide and Sertraline extracted into EthylAcetate. Addition of Hydrochloric Acid to Ethyl Acetate extract of Sertraline gives Sertraline Hydrochloride.

PRODUCT : Sertraline Hydrochloride

Monomethylamine solution (25%) in Methanol

Schiff Base is reduced with Sodium Borohydride in Methanol media and neutralized with Hydrochloric Acid togive Cis-Racemate Hydrochloride.

Cis-Racemate Hydrochloride is reacted with Mandelic acid in Ethyl Acetate solvent media to get CrudeSertraline Mandelate salt. Crude Sertraline Mandelate salt is purified with Ethanol toget Pure SertralineMandelate salt.

Description :Tetralone on reaction with Monomethylamine in Methanol gives Schiff Base.

Stage I

Stage II

Stage III

Stage IV

ANNEXURE - XIII

64

Dimethyl amino propyl Chloride Hydrochloride is reacted with Sodium Hydroxide to get Dimethyl amino propyl Chloride (Stage-1) Compound.

Citalopram Base is reacted with Hydrobromic Acid in Isopropyl Alcohol and Isopropyl Ether to get Citalopram Hydrobromide Tech (Stage-4) Compound.

Citalopram Hydrobromide Tech is purified in Acetone to give Citalopram Hydrobromide Pharma.

Stage 2 compound is cyclised in presence of Ortho Phosphoric Acid to get Citalopram Base.

Description :

Stage-1 Compound is reacted with Magnesium, 1-Bromo-4-Fluoro Benzene, 5-Cyanophthalide and Water inToluene and THF to get (Stage-2) Compound.

PRODUCT : Citalopram Hydrobromide

ANNEXURE - XIII

65

Flow Chart

Potassium Hydroxide EffluentSodium HydroxideWater

Stage-1Magnesium Sol.Recovery1-Bromo-4-Fluoro Benzene Evaporation LossEthylene di bromide Organic Residue5-Cyanophthalide EffluentToluene Inorganic Solid WasteTetrahydrofuranAmmonium ChlorideLiq.Ammonia (20%)Acetic AcidWater

Stage-2Ortho Phosphoric Acid Sol.RecoveryToluene Evaporation LossLiq.Ammonia (20%) EffluentWater Organic Residue

Citalopram BaseHydrobromic Acid (48%) Sol.RecoveryIsopropyl Alcohol Evaporation LossIsopropyl Ether Organic Residue

Citalopram Hydrobromide (Tech)Acetone Sol.RecoveryCarbon Evaporation LossWater Effluent

Organic ResidueSpent Carbon

Citalopram Hydrobromide


Dimethyl amino Propyl Chloride Hydrochloride (60%)

Stage I

Stage II

Stage III

Stage IV

Stage V

ANNEXURE - XIII

66

Stage-1

Stage-2

Flow Chart

1-NaphtholEpichlorohydrin Sol.RecoverySodium Hydroxide Evaporation LossWater EffluentMethylene Dichloride Organic Residue

Stage-1Isopropylamine Sol.RecoveryEthanol Evaporation LossWater EffluentToluene Organic Residue

Propranolol

PRODUCT : Propranolol

Description :

1-naphthol reacts with epichloro hydrin to form the 2-[(1-Naphthyloxy) methyl oxirane the presence of sodium hydroxide solutions. The product is extracted with Methylene Dichloride. Distill off Methylene Dichloride to get the product.

Stage-1 compound reacts with Isopropyl amine in the presence of ethanol at 100oC at 2-3 KG pressure to form Propranolol. The product is extracted with Toluene. Distill off toluene to get the compound.

Stage I

Stage II

ANNEXURE - XIII

67

Stage-2

Stage-3

Flow Chart

7-Hydroxy carbostyril1,4-Dibromobutane Sol.RecoveryToluene Evaporation LossPotassium Carbonate EffluentSodium Sulfite Organic ResidueWater Inorganic Solid Waste

Process Emissions

Stage-1 Sol.RecoveryEvaporation Loss

Send to Auth. PartyToluene EffluentSodium Hydroxide Organic ResidueWater

Aripiprazole (crude)Sol.Recovery

Evaporation LossWater Effluent

Organic Residue

Isopropyl Alcohol Hydrochloride (20%)

2,3-Dichlorophenyl Piperazine HCl

If TLC complies adjust the PH with IPA HCl to 2.2-2.6 at the temp 10-15oC fo r2 hrs. Centrifuge the material. And unload the material.

Description :

Stage-1

In the first stage take toluene and Potassium carbonate. Azeotropically remove traces of water and then cool to RT and then add 7-hydroxy carbostyril slowly raise the temeperature to 80oC, by addition add 1,4-Dibromobutane at 80-82oC, maintain for 7 hrs. After reaction is completed separate toluene layer and wash with water. Dry the toluene layer with sodium sulphite then distill off toluene, cool to 20oC and centrifuge the material filter and unload the material.

Take toluene dissolve stage-1 mean while take another SS Reactor take NaOH solution dissolve 2,3-Dichlorophenyl piperazine. HCl than add stage-1 in toluene into the second reactor after addtion maintian the temp 35-40oC check TLC.

Aripiprazole

PRODUCT : Aripiprazole

Stage I

Stage II

Stage III

ANNEXURE - XIII

68

STAGE-I :

STAGE II :

STAGE-III :

Flow Chart

Ortho PhenyldiamineMethyl acetoacetate Sol.RecoveryXylene Evaporation Lossn-Hexane EffluentWater Organic Residue

Process Emissions

Stage-1Toluene Sol.Recovery1-Bromo-3-Chloro propane Evaporation LossSodium Hydroxide EffluentHydrochloric Acid (36%) Organic ResidueWater

Stage-2Benzhydryl Piperazine Sol.RecoveryToluene Evaporation LossPotassium Carbonate EffluentWater Organic Residue

Process Emissions

Oxatomide

PRODUCT : OxatomideDescription :

Take xylene dissolve Ortho phenyl diamine slowly raise temperature 70 o C add methyl acetoacetate in 4 hrs. After completion of addition raise the temp to 80-85oC check the TLC Ortho phenyl diamine and it should be nil . If TLC complies distill off Xylene unload the stage-I material..

Add 1-bromo,3-chloro propane, Toluene Stage-1 mix and Sodium hydroxide at RT raise the Temp to 40oC. Maintain 40- 42oC for 15 hrs. Check the TLC starting material should be nil. If TLC complies cool to RT centrifuge to get stage-2 material.

Take stage-II Potassium Carbonate maintain ½ hr at R T add Benzhydryl piperizine raise the temp to 98-100oC maintain for 5 hrs. check HPLC .If HPLC complies add water separate the organic layer wash with water at 70oC organic layer cool to 5 – 10 o C .Centrifuge the material to get Oxatomide.

Stage I

Stage II

Stage III

ANNEXURE - XIII

69

Raw Material

Consumption of Raw

Material / Kg of Product

Daily Consumption of

Raw Material

Kg Kg2,3-Lutidine = 0.460 30.672-Mercapto Benzimidazole = 0.485 32.333-Methoxy-1-Propanol = 0.400 26.67Acetic acid = 0.460 30.67Acetic Anhydride = 1.500 100.00Carbon = 0.100 6.67DMSO = 1.950 130.00Hydrogen Chloride gas = 0.130 8.67Hydrogen peroxide(50%) = 0.330 22.00Isopropyl Alcohol = 3.000 200.00Methylene Dichloride = 5.000 333.33n-Hexane = 2.500 166.67Nitric Acid = 0.300 20.00Sodium Hydroxide = 0.891 59.40Sodium Hypochlorite(4%) = 5.425 361.67Sulfuric Acid = 1.080 72.00Thionyl Chloride = 0.385 25.67Toluene = 20.500 1366.67

PRODUCT : Rabeprazole SodiumLIST OF RAW MATERIALS

ANNEXURE - XIV

70

Raw Material

Consumption of Raw



Raw Material

Kg Kg2,3-Lutidine = 0.460 30.672-Mercapto Benzimidazole = 0.490 32.67Acetic acid = 0.640 42.67Acetic Anhydride = 1.300 86.67Acetone = 1.250 83.33Activated Carbon = 0.030 2.00Catalyst = 0.010 0.67Chloroform = 4.650 310.00Hydrochloric Acid gas = 0.140 9.33Hydrogen Peroxide (50%) = 0.550 36.67Isopropyl Alcohol = 2.500 166.67Methylene Dichloride = 1.750 116.67MIBK = 1.300 86.67Nitric Acid = 0.300 20.00Potassium Carbonate = 0.530 35.33Sodium Hydroxide = 0.600 40.00Sulfuric Acid = 1.080 72.00TEBAC = 0.010 0.67Thionyl Chloride = 0.410 27.33Toluene = 4.600 306.67Tri Fluoro Ethanol = 0.390 26.00


LIST OF RAW MATERIALS

ANNEXURE - XIV

71

Raw Material

Consumption of Raw



Raw Material

Kg Kg5-Difluoromethoxy-2-mercapto benzimidazole = 0.70 46.67

Acetic acid = 0.40 26.67Acetic anhydride = 0.40 26.67Acetone = 10.00 666.67Ammonium carbonate = 0.65 43.33Carbon = 0.10 6.67Dimethyl Sulfate = 0.45 30.00Ethylene dichloride = 3.60 240.00Hydrogen peroxide (50%) = 0.40 26.67Maltol = 0.85 56.67Methanol = 4.15 276.67Methylene dichloride = 7.15 476.67n-Hexane = 4.00 266.67Phosphorus oxychloride = 0.35 23.33Potassium carbonate = 0.55 36.67Sodium hydroxide = 0.72 48.00Sodium Hypochlorite = 0.20 13.33Sodium Methoxide = 0.23 15.33Thionyl chloride = 0.39 26.00Toluene = 11.05 736.67

PRODUCT : PantoprazoleLIST OF RAW MATERIALS

ANNEXURE - XIV

72

Raw Material

Consumption of Raw



Raw Material

Kg Kg2-(Dimethylamine)ethylchloride = 0.5 16.672-Chloro Pyridine = 0.6 20.00Bromine = 0.82 27.33Methanol = 2.5 83.33Phenyl acetonitrile = 0.6 20.00Sodamide = 0.8 26.67Sodium Hydroxide = 0.35 11.67Sodium Methoxide = 0.3 10.00Toluene = 6.68 222.67

Raw Material

Consumption of Raw



Raw Material

Kg Kg2-Methyl-2-Propyl Propane-1,3-diol = 0.78 260.00Activated Carbon = 0.09 30.00Chloroform = 10 3333.33Dimethyl carbonate = 1.06 353.33Hydrochloric Acid gas = 0.235 78.33Isopropylamine = 0.836 278.67Methanol = 3.345 1115.00Sodium Cyanate = 0.457 152.33Sodium Methoxide = 0.006 2.00Toluene = 10.1 3366.67

PRODUCT : CarisoprodolLIST OF RAW MATERIALS



ANNEXURE - XIV

73

Raw Material

Consumption of Raw



Raw Material

Kg Kg1,4-Dioxane = 5 2000.003-Hydroxy Acetophenone = 1 400.00AIBN = 0.01 4.00Bromine = 1.177 470.80Carbon = 0.1 40.00Hydrogen = 0.11 44.00Isopropyl Alcohol Hydrochloride (20%) = 1.5 600.00Methanol = 1.1 440.00N-Methyl benzylamine = 0.8 320.00Palladium Carbon = 0.01 4.00Sodium Sulfate = 0.02 8.00Toluene = 1 400.00

Raw Material

Consumption of Raw



Raw Material

Kg Kg11-Piperazin dibenzo[b,f] [1,4] Thiazepine dihydrochloride = 1.05 35.00

2-Chloroethoxy Ethanol = 0.355 11.83Carbon = 0.07 2.33Ethyl Acetate = 5.6 186.67Fumaric acid = 0.15 5.00Isopropyl Alcohol = 14.9 496.67Sodium Carbonate = 0.55 18.33

PRODUCT : Quetiapine Hemifumarate


PRODUCT : Phenylephrine Hydrochloride


ANNEXURE - XIV

74

Raw Material

Consumption of Raw



Raw Material

Kg KgTetralone = 4.8 1600.00Activated Carbon = 0.03 10.00Ammonia solution(18%) = 1.11 370.00Ethanol = 18 6000.00Ethyl Acetate = 30 10000.00Hydrochloric Acid (35%) = 1.996 665.33Hyflo = 0.05 16.67Mandelic acid = 1.15 383.33Methanol = 42 14000.00Monomethylamine solution (25%) in Methanol = 8.5 2833.33Sodium Borohydride = 0.178 59.33Sodium Hydroxide = 0.255 85.00

Raw Material

Consumption of Raw



Raw Material

Kg KgDimethyl amino Propyl Chloride Hydrochloride (60%) = 1.3 86.671-Bromo-4-Fluoro Benzene = 0.72 48.005-Cyanophthalide = 0.66 44.00Acetic Acid = 0.5 33.33Acetone = 3.3 220.00Ammonium Chloride = 0.6 40.00Carbon = 0.06 4.00Ethylene di bromide = 0.04 2.67Hydrobromic Acid (48%) = 0.521 34.73Isopropyl Alcohol = 2.5 166.67Isopropyl Ether = 3.7 246.67Liq.Ammonia (20%) = 3.4 226.67Magnesium = 0.2 13.33Ortho Phosphoric Acid = 1.5 100.00Potassium Hydroxide = 0.06 4.00Sodium Hydroxide = 0.2 13.33Tetrahydrofuran = 7 466.67Toluene = 25 1666.67

PRODUCT : Sertraline Hydrochloride




ANNEXURE - XIV

75

Raw Material

Consumption of Raw



Raw Material

Kg Kg1-Naphthol = 0.8 53.33Epichlorohydrin = 0.6 40.00Ethanol = 3 200.00Isopropylamine = 0.8 53.33Methylene Dichloride = 3 200.00Sodium Hydroxide = 0.3 20.00Toluene = 4 266.67

Raw Material

Consumption of Raw



Raw Material

Kg Kg1,4-Dibromobutane = 0.7 23.332,3-Dichlorophenyl Piperazine HCl = 0.8 26.677-Hydroxy carbostyril = 0.5 16.67Isopropyl Alcohol Hydrochloride (20%) = 0.6 20.00Potassium Carbonate = 0.3 10.00Sodium Hydroxide = 0.26 8.67Sodium Sulfite = 0.01 0.33Toluene = 9.6 320.00


PRODUCT : PropranololLIST OF RAW MATERIALS

PRODUCT : Aripiprazole

ANNEXURE - XIV

76

Raw Material

Consumption of Raw



Raw Material

Kg Kg1-Bromo-3-Chloro propane = 0.53 17.67Benzhydryl Piperazine = 0.7 23.33Hydrochloric Acid (36%) = 0.13 4.33Methyl acetoacetate = 0.54 18.00n-Hexane = 0.15 5.00Ortho Phenyldiamine = 0.4 13.33Potassium Carbonate = 0.3 10.00Sodium Hydroxide = 0.15 5.00Toluene = 5.1 170.00Xylene = 3.77 125.67

PRODUCT : OxatomideLIST OF RAW MATERIALS

ANNEXURE - XIV

77

List of Hazardous Materials

Raw Material

1,4-DioxaneAmmonia solution(18%)BromineChloroform EpichlorohydrinEthylene dichlorideMethylene DichlorideTetrahydrofuranThionyl Chloride

ANNEXURE - XV

78

Effluent Treatment Flow Scheme - ZLD

ANNEXURE - XVI

79

Schematic flow Sheet for EIA Procedure

Time schedule for obtaining the EC from MOEF

Submission of application by proponent (Form 1, Pre-feasilibility report and Draft Terms of Reference)

Scrutiny by EAC

Scoping an communication of Terms of Reference for EIA Studies to the Proponent for EIA preparation

Submission of proceedings of the public hearing by the SPCB / PCC to EAC

Conducting public hearing by SPCB / PCC or any other public Agency / authority engaged by regulatory authority

Submission of Draft EIA / Summary EIA / Application for Public consultation

Appraisal by EAC

Submission of final EIA by the proponent after improving EIA / EMP

Decision of MoEF

Decision of MoEF

Specific Concerns

Yes NO Rejection

Issuing clearance to project proponent

60 days

45 days

60 days

Scop

ing

Publ

ic C

onsu

ltanc

y De

cisio

n M

akin

g Ap

prai

sal

Reservation on the proposal conveyed to EAC

EAC views on reservations sent to MoEF

45 days

60 days

30 days

Category A Project

Preparation of FORM I Application & Prefeasibility report

30 days on obtaining information from industry

as per check list

Preparation of Draft EIA report 120 days minimum other than monsoon period of 120 days

30 days for preparation of Final REIA Maximum

ANNEXURE - XVII

80

Environmental Baseline Monitoring (To Establish quality of the

Environment)

Application of Impact Prediction Tools (Quantitative Significance Analysis)

Identification of Likely Impacts (Quantitative Significance Analysis

(Ref: Impact Matrix)

EIA Team

Social Impact Assessment

Risk Assessment

Project Features (Pre-feasibility Report,

Form1)

Valued Environment Components

Mitigation Measures

Environmental Management Plan

Reporting

Approach of EIA Study – 4 months other than monsoon period after obtaining TOR copy from MOEF

ANNEXURE - XVII

81

Topomap of 10 km Radius – M/s. Tejashrri Intermediates Pvt. Ltd.

ANNEXURE - XVIII

82

pre-feasibility report - environmentclearance.nic.in · pre-feasibility report highlighting the...

Documents